LQDA Q1 2022 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+13.2% YoY

Gross Profit

$3M80.1% margin

Operating Income

-$14M-414.4% margin

Net Income

-$16M-456.6% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+8.6%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$94M

Total Liabilities

$38M

Stockholders' Equity

$55M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+13.2%
Gross Profit	$3M	$2M	+17.1%
Operating Income	-$14M	-$9M	-60.8%
Net Income	-$16M	-$9M	-73.6%